Substance / Medication

Abatacept

Overview

Active Ingredient
abatacept
RxNorm CUI
614391
Labeler: E.R. Squibb & Sons, L.L.C.Updated: 2025-11-13T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

None.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

31 trials linked to this intervention

31
Total Trials
5
Recruiting
14
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Abatacept and the risk of malignancy: a meta-analysis across disease indications.
Zuckerman Benjamin P, Gibson Mark, Roy Ritika et al. · Rheumatology (Oxford) · 2025
PMID: 39992258Meta-AnalysisFull text (PMC)
Efficacy and safety of abatacept in preclinical rheumatoid arthritis: A systematic review and meta-analysis of randomized controlled trials.
Asif Maheen, Asif Aliza, Rahman Ummi Aiman et al. · Semin Arthritis Rheum · 2024
PMID: 39393109Meta-Analysis
Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review.
Nishimura Kenichi, Ishikawa Takashi, Okamoto Nami et al. · Mod Rheumatol · 2024
PMID: 38753302Meta-Analysis
Analysis of efficacy and safety of abatacept for rheumatoid arthritis: systematic review and meta-analysis.
Mohamed Ahamada Mariame, Wu Xiaochuan · Clin Exp Rheumatol · 2023
PMID: 36912326Meta-Analysis
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.
Vicente-Rabaneda Esther F, Atienza-Mateo Belén, Blanco Ricardo et al. · Autoimmun Rev · 2021
PMID: 33887489Meta-Analysis
Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature.
Bowlus Christopher L, Yang Guo-Xiang, Liu Chung H et al. · J Autoimmun · 2019
PMID: 31027870Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Specialists

Providers who commonly manage this intervention

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Abatacept (substance)
SNOMED CT
421777009
UMLS CUI
C1619966
RxNorm CUI
614391
Labeler
E.R. Squibb & Sons, L.L.C.

Clinical Data

This intervention maps to 8 entities in the Healos knowledge graph.

3
Conditions
2
Biomarkers
1
Specialists
0
Symptoms
31
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.